Last $107.24 USD
Change Today +1.45 / 1.37%
Volume 1.0
MKGAF On Other Exchanges
As of 10:52 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

merck kgaa (MKGAF) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/3/15 - $107.24
52 Week Low
04/16/14 - $79.01
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MERCK KGAA (MKGAF)

Related News

No related news articles were found.

merck kgaa (MKGAF) Related Businessweek News

No Related Businessweek News Found

merck kgaa (MKGAF) Details

Merck KGaA, together with its subsidiaries, discovers, develops, manufactures, and markets products in the pharmaceutical and chemical sectors worldwide. It operates through four divisions: Merck Serono, Consumer Health, Performance Materials, and Merck Millipore. The Merck Serono division provides prescription medicines for the treatment of cancer, multiple sclerosis, infertility, growth disorders, cardiovascular, and metabolic diseases and allergies. The Consumer Health division offers over-the-counter pharmaceuticals for mobility and agility, everyday health protection, women’s and children’s health, and cough and cold under the Bion 3, Nasivin, Femibion, Seven Seas, Sangobion, Cebion, Sedalmerck, and Kytta brand names. The Performance Materials division provides specialty chemicals for use in various end products, such as liquid crystals for displays; LED materials for lighting, and OLED materials for lighting and displays; functional materials for solar panels and energy solutions; pigments, active ingredients, and fillers for cosmetics, food, and pharmaceutical products; and pigments and functional materials for coatings, printing, and plastics. The Merck Millipore division offers tools and laboratory chemicals that are used in the research, pharmaceutical and biotechnology industries, and analytical and clinical laboratories. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA is a subsidiary of E. Merck KG.

39,355 Employees
Last Reported Date: 11/13/14
Founded in 1668

merck kgaa (MKGAF) Top Compensated Officers

Chairman of Executive Board and Chief Executi...
Total Annual Compensation: €5.4M
Chief Executive Officer of Life Science & Per...
Total Annual Compensation: €4.5M
General Partner and Member of Executive Board
Total Annual Compensation: €3.7M
Vice Chairman of Executive Board
Total Annual Compensation: €4.5M
Compensation as of Fiscal Year 2013.

merck kgaa (MKGAF) Key Developments

Merck Announces Personnel Changes in Finance Function

Merck announced that Andreas Stickler has been appointed as new Head of Controlling of the Healthcare Business Sector. Roman Morten Werth will succeed Andreas Stickler in his current position as Head of Mergers & Acquisitions (M&A). The changes will take effect on Feb. 1, 2015. In his new role, Andreas Stickler will be responsible for the three Business Sectors, which have been introduced on Jan. 1, 2015. In addition to the biopharmaceutical business Merck Serono, the Business Sector Healthcare also comprises the businesses Consumer Health, Biosimilars and Allergopharma. Andreas Stickler has headed the M&A department since 2008 and in that role led major transactions, including the takeover of Millipore (2010), AZ Electronic Materials (2014) and the planned acquisition of Sigma Aldrich (announced 2014). He joined Merck in 2002, following positions at Degussa, Aventis and Hoechst. Roman Werth joined the M&A department at Merck in 2008 and has played a key role in executing all major M&A projects.

Merck KGaA, Q4 2014 Earnings Call, Mar 03, 2015

Merck KGaA, Q4 2014 Earnings Call, Mar 03, 2015

Merck KGaA Presents at Commerzbank German Investment Seminar, Jan-12-2015

Merck KGaA Presents at Commerzbank German Investment Seminar, Jan-12-2015 . Venue: New York, New York, United States. Speakers: Marcus Kuhnert, Group Chief Financial Officer and Member of Executive Board.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MKGAF:US $107.24 USD +1.45

MKGAF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Koninklijke DSM NV €49.33 EUR -0.56
PPG Industries Inc $235.01 USD -2.69
Seiko Epson Corp ¥4,545 JPY +55.00
Solvay SA €128.70 EUR -1.35
Sherwin-Williams Co/The $286.05 USD -4.84
View Industry Companies

Industry Analysis


Industry Average

Valuation MKGAF Industry Range
Price/Earnings 30.7x
Price/Sales 3.2x
Price/Book 3.0x
Price/Cash Flow 5.4x
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK KGAA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at